Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last A$0.09 AUD
Change Today -0.002 / -2.20%
Volume 1.2M
NEU On Other Exchanges
Symbol
Exchange
OTC US
As of 1:59 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

697 Burke Road

Suite 501

Camberwell, VIC 3124

Australia

Phone: 61 3 9092 0480

Fax:

Neuren Pharmaceuticals Limited, a biopharmaceutical company, focuses on the development of therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Its products in development include Trofinetide, which is in Phase II clinical trials for use in the treatment of Rett syndrome, Fragile X syndrome, moderate to severe traumatic brain injury, and concussion; and NNZ-2591, a synthetic analogue of a naturally occurring neuropeptide that is in preclinical development for the treatment of various neurodegenerative disorders. The company has collaborative relationships with the US Army Medical Research & Materiel Command; and the Walter Reed Army Institute of Research. Neuren Pharmaceuticals Limited is based in Camberwell, Australia.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEU:AU A$0.09 AUD -0.002

NEU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NEU.
View Industry Companies
 

Industry Analysis

NEU

Industry Average

Valuation NEU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 49.0x
Price/Book 9.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 39.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEUREN PHARMACEUTICALS LTD, please visit www.neurenpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.